R-Pharm concludes deal to sell 10% of shares to Japan's Mitsui

Home > Newsroom > Top Stories > R-Pharm concludes deal to sell 10% of shares to Japan's Mitsui

R-Pharm concludes deal to sell 10% of shares to Japan's Mitsui

MOSCOW. Oct 17 (Interfax) - Alexey Repik's pharmaceutical company R-Pharm has concluded a deal with Japan's Mitsui & Co on the sale of 10% of its shares, the Russian company said in a statement.

Mitsui's acquisition of a 10% stake in R-Pharm for $200 million was announced in April. The buyer has an option to increase its stake to 20%.

"The agreement fully corresponds to our core strategic goals and boosts the importance of the Russian pharmaceutical industry and biotechnologies on the global stage, especially in the area of research and development," R-Pharm chairman Alexey Repik was cited as saying in the statement.